BPB Reports
Online ISSN : 2434-432X
Report
Anti-proliferative effects of (–)-isostemonamine on highly aggressive human breast cancer MDA-MB-231 cells
Masayo Hirao-SuzukiShuso TakedaTakayuki IwataSatoshi FujitaTaishi TomiyamaMasufumi TakiguchiMitsuru Shindo
Author information
JOURNAL OPEN ACCESS FULL-TEXT HTML

2018 Volume 1 Issue 2 Pages 32-34

Details
Abstract

Stemona alkaloids such as (±)-stemonamine/ (±)-isostemonamine, have a unique structure, possibly coupled with potential biological activities. The establishment of effective total synthesis protocols for stemonamine alkaloids has been a challenge for synthetic chemists so far. These stemonamine alkaloids are isolated as racemates and there is no report concerning their asymmetric total synthesis. It is generally understood that any pair of enantiomers have physically and chemically indistinguishable properties. However, stereochemistry is a critical point in biological systems because most biological reactions, such as those mediated by enzymes and receptors, are stereospecific. We have successfully established the methods of asymmetric total synthesis of the stemonamine alkaloids, (–)-stemonamine/(–)-isostemonamine. We studied the potential application of these Stemona alkaloids as anti-proliferative agents. Experiments were conducted by using two representative human breast cancer cell lines, MCF-7 and MDA-MB-231, and our results indicated that i) (–)-isostemonamine displays strong cytotoxic effects on the highly aggressive estrogen receptor α (ERα)-negative MDA-MB-231 cell line, but not on the ERα-positive MCF-7 cells, with an IC50 value (9.3 ± 1.9 μM), which is comparable to that of etoposide (IC50 = 7.1 μM ± 1.4 μM), and ii) the thioamide derivative of (–)-isostemonamine does not suppress the growth of MDA-MB-231 cells.

Content from these authors
© 2018 The Pharmaceutical Society of Japan

BPB Reports applies the Creative Commons Attribution (CCBY) license to works we published. The license was developed to facilitate open access - namely, free immediate access to, and unrestricted reuse of, original works to all types. Under this license, authors agree to make articles legally available for reuse, without permissions of fees, for virtually any purpose. Anyone may copy, distribute, or reuse these articles, as long as the author and original source are properly cited.
https://creativecommons.org/licenses/by/4.0/
Next article
feedback
Top